Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
2
×
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
buyout
2
×
celgene
detroit blog main
detroit top stories
drug prices
indiana blog main
indiana top stories
life sciences
m&a
national
national blog main
national top stories
new york blog main
new york top stories
pricing
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
2019
acquisition
activism
acute hepatic porphyria
adaptimmune
allergan
allogeneic
What
advanced
airport
alnylam’s
annual
apocalypse
approval
beds
bff
bio
celgene
conference
days
deals
devoted
disease
drug
easl
fallout
form
gene
gone
home
j.p
jpm
kicked
liver
major
notes
price
race
roundup
sleep
staggers
therapy
time
treat
updates
vortex
world's
Language
Current search:
buyout
×
" boston blog main "
×
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More
